372320 — Curocell Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Curocell, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-53,576	-38,885	-29,575	-38,238	-46,305
Depreciation
Amortisation
Non-Cash Items	41,448	21,109	372	4,705	12,287
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-1,123	1,557	-767	-1,224	-2,097
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-11,536	-14,392	-25,264	-28,422	-29,993
Capital Expenditures	-9,299	-27,870	-21,650	-1,210	-2,215
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	17,794	-12,851	524	23,230	-6,976
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	8,495	-40,721	-21,127	22,020	-9,192
Financing Cash Flow Items	-18.2	—	—	-6.82	56.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	42,224	19,148	49,682	1,042	44,797
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	39,183	-35,964	3,291	-5,337	5,584